Vestal Point Capital »

Ascendis Pharma AS shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $100M 375k 266.72

More positions owned by Vestal Point Capital

BioMarin Pharmaceutical (BMRN)
Neurocrine Biosciences (NBIX)
Abivax SA Sponsored Ads (ABVX)
United Therapeutics Corporation (UTHR)
Enliven Therapeutics (ELVN)
Nurix Therapeutics (NRIX)
Bicara Therapeutics (BCAX)
Taysha Gene Therapies Com Shs (TSHA)
Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories (ABT)
Zimmer Holdings (ZBH)
Disc Medicine (IRON)
Monte Rosa Therapeutics (GLUE)
Insulet Corporation (PODD)
Ascendis Pharma A/S Ord Shs (ASND)

View all positions for Vestal Point Capital

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS